Report Type: Therapy Reports
Report Category: Respiratory
Report Subcategory: Chronic Obstructive Pulmonary Disease or COPD
Price: $2999.00

Date: January 2022

Chronic Obstructive Pulmonary Disease or COPD: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Chronic Obstructive Pulmonary Disease or COPD
Chronic Obstructive Pulmonary Disease or COPD is a pulmonary or lung diseases that block or obstruct the airflow and make it difficult to breathe.

Top 10 Companies:

Johnson & Johnson
F. Hoffmann-La Roche Ltd
Pfizer Inc
Bayer AG
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
AbbVie Inc
Takeda Pharmaceutical Co Ltd
Bristol-Myers Squibb Co